NASDAQ
Intensity Therapeutics, Inc. (INTS) has a current ratio of 5.92x as of Monday, May 25, 2026. This represents a 224.22% increase compared to its 12-month average of 1.83x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.